SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q1 2014 13F Holders as of 31 Mar 2014
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 14,476,121
- Share change
- +1,855,826
- Total reported value
- $104,126,600
- Put/Call ratio
- 104%
- Price per share
- $7.20
- Number of holders
- 51
- Value change
- +$13,345,733
- Number of buys
- 31
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.4%
|
3,888,473
|
$23,797,000 | — | 31 Dec 2013 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.3%
|
1,637,500
|
$10,022,000 | — | 31 Dec 2013 | |
| DAVIS SELECTED ADVISERS |
13F
|
Company |
1.6%
|
1,178,606
|
$7,213,000 | — | 31 Dec 2013 | |
| FIL Ltd |
13F
|
Company |
1.5%
|
1,069,500
|
$6,545,000 | — | 31 Dec 2013 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
1,054,996
|
$6,457,000 | — | 31 Dec 2013 | |
| Visium Asset Management, LP |
13F
|
Company |
1.4%
|
1,000,000
|
$6,120,000 | — | 31 Dec 2013 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.88%
|
633,364
|
$3,876,000 | — | 31 Dec 2013 | |
| Pine River Capital Management L.P. |
13F
|
Company |
0.69%
|
494,646
|
$3,028,000 | — | 31 Dec 2013 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.63%
|
453,900
|
$2,778,000 | — | 31 Dec 2013 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
229,748
|
$1,406,000 | — | 31 Dec 2013 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.26%
|
184,947
|
$1,130,000 | — | 31 Dec 2013 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.11%
|
75,900
|
$483,000 | — | 31 Dec 2013 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
64,607
|
$396,000 | — | 31 Dec 2013 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
60,518
|
$370,000 | — | 31 Dec 2013 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.08%
|
56,000
|
$343,000 | — | 31 Dec 2013 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.06%
|
43,650
|
$267,000 | — | 31 Dec 2013 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.05%
|
36,972
|
$226,000 | — | 31 Dec 2013 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.05%
|
34,458
|
$211,000 | — | 31 Dec 2013 | |
| ELLINGTON MANAGEMENT GROUP LLC |
13F
|
Company |
0.05%
|
33,800
|
$207,000 | — | 31 Dec 2013 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.04%
|
27,623
|
$169,000 | — | 31 Dec 2013 | |
| ProShare Advisors LLC |
13F
|
Company |
0.03%
|
24,134
|
$148,000 | — | 31 Dec 2013 | |
| WESTPORT RESOURCES MANAGEMENT INC |
13F
|
Company |
0.03%
|
22,925
|
$140,000 | — | 31 Dec 2013 | |
| Jane Street Holding, LLC |
13F
|
Company |
0.02%
|
17,000
|
$104,000 | — | 31 Dec 2013 | |
| PDT Partners, LLC |
13F
|
Company |
0.02%
|
12,000
|
$73,000 | — | 31 Dec 2013 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
11,020
|
$67,000 | — | 31 Dec 2013 | |
| NAVELLIER & ASSOCIATES INC |
13F
|
Company |
0.01%
|
10,250
|
$63,000 | — | 31 Dec 2013 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
10,248
|
$62,000 | — | 31 Dec 2013 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
7,755
|
$47,000 | — | 31 Dec 2013 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
7,517
|
$46,000 | — | 31 Dec 2013 | |
| UBS AG |
13F
|
Company |
0.01%
|
7,382
|
$45,000 | — | 31 Dec 2013 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
3,800
|
$23,256 | — | 31 Dec 2013 | |
| Creative Planning |
13F
|
Company |
0%
|
1,000
|
$6,000 | — | 31 Dec 2013 | |
| MSI Financial Services Inc |
13F
|
Company |
0%
|
1,000
|
$6,000 | — | 31 Dec 2013 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
750
|
$5,000 | — | 31 Dec 2013 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
734
|
$4,000 | — | 31 Dec 2013 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
596
|
$4,000 | — | 31 Dec 2013 | |
| Apriem Advisors |
13F
|
Company |
0%
|
300
|
$2,000 | — | 31 Dec 2013 | |
| WFG Advisors, LP |
13F
|
Company |
0%
|
200
|
$1,000 | — | 31 Dec 2013 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
153
|
$1,000 | — | 31 Dec 2013 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q1 2014
As of 31 Mar 2014,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,476,121 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT CO LLP, ORBIMED ADVISORS LLC, DAVIS SELECTED ADVISERS, FIL Ltd, RENAISSANCE TECHNOLOGIES LLC, Visium Asset Management, LP, BlackRock Fund Advisors, PICTET ASSET MANAGEMENT LTD, JANE STREET GROUP, LLC, and BOGLE INVESTMENT MANAGEMENT L P /DE/.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2014 vs Q4 2013 Across Filers
Q4 2013 holders
40
Q1 2014 holders
51
Holder diff
11
| Investor | Q4 2013 Shares | Q1 2014 Shares | Share Diff | Share Chg % | Q4 2013 Value $ | Q1 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.